Farhan Rafi, MD
Family Medicine · Coppell, TXNPI 1912387069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for family medicine clinicians in TX, where the typical reported total is $436.
Across 21 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$91
- Novo Nordisk$63
- Saluda Medical Americas, Inc.$43
- Boehringer Ingelheim$41
- AbbVie$41
- Nalu Medical, Inc.$35
- plus $176 from 8 others
What the payments were for
- Food & beverage$491100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $91 |
| Novo Nordisk | 4 | $63 |
| Saluda Medical Americas, Inc. | 1 | $43 |
| Boehringer Ingelheim | 2 | $41 |
| AbbVie | 2 | $41 |
| Nalu Medical, Inc. | 1 | $35 |
| Exact Sciences | 2 | $35 |
| Tris Pharma Inc | 2 | $31 |
| Corium, LLC | 1 | $24 |
| Pfizer | 1 | $23 |
| Corcept Therapeutics | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Neos Therapeutics, LP | 1 | $13 |
How this compares
$491 in reported general payments places this provider in the 50th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $662 |
| Atorvastatin Calcium | 43 | $285 |
| Levothyroxine Sodium | 27 | $207 |
| Gabapentin | 11 | $175 |
| Escitalopram Oxalate | 14 | $158 |
| Amlodipine Besylate | 22 | $126 |
| Losartan Potassium | 24 | $72 |
| Metformin Hcl | 17 | $71 |
| Lisinopril | 19 | $68 |
| Simvastatin | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Coppell
- Victor BurgosCoppell$124K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.